We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
People.
- Abstract
The article focuses on personnel changes taking place in various pharmaceutical companies. Guava Technologies Inc. has named Lawrence F. Bruder to the position of president and COO. Windber Research Institute has named retired brigadier general Michael Dunn as chief medical officer to pursue genomic and proteomic research on cancer, cardiac disease and complimentary medicine. Generic drug developer Actavis Group has announced the appointment of Mark Keatley as chief executive of finance, as well as a member of the group's executive board.
- Subjects
PERSONNEL management; PERSONNEL changes; RESEARCH institutes; GUAVA Technologies Inc.; BRUDER, Lawrence F.; KEATLEY, Mark
- Publication
Nature Biotechnology, 2005, Vol 23, Issue 9, p1186
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0905-1186